COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U. Niemann; Farrukh T. Awan; Laura Fogliatto; Eugene Nikitin; Olga Samoilova; Adel Habib; Kayhan Foroutanpour; Nataliya Kuptsova-Clarkson; Stephen Opat

doi:10.1097/HS9.0000000000000780

COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U. Niemann, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, Kayhan Foroutanpour, Nataliya Kuptsova-Clarkson, Stephen Opat

Medicine Monash Health

Research output: Contribution to journal › Article › Research › peer-review

7 Citations (Scopus)

Original language	English
Article number	E780
Pages (from-to)	1-4
Number of pages	4
Journal	HemaSphere
Volume	6
Issue number	10
DOIs	https://doi.org/10.1097/HS9.0000000000000780
Publication status	Published - 22 Oct 2022

Access to Document

10.1097/HS9.0000000000000780Licence: CC BY-NC-ND

Cite this

@article{593b5fdc39714153b352e742e2fc2a5a,

title = "COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study",

author = "Niemann, \{Carsten U.\} and Awan, \{Farrukh T.\} and Laura Fogliatto and Eugene Nikitin and Olga Samoilova and Adel Habib and Kayhan Foroutanpour and Nataliya Kuptsova-Clarkson and Stephen Opat",

note = "Funding Information: Writing and editorial assistance were provided by Robert J. Schoen, PharmD, and Laura L. McCormick, PhD, of Peloton Advantage, an OPEN Health company, and funded by AstraZeneca. ",

year = "2022",

month = oct,

day = "22",

doi = "10.1097/HS9.0000000000000780",

language = "English",

volume = "6",

pages = "1--4",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Lippincott Williams \& Wilkins",

number = "10",

}

TY - JOUR

T1 - COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

AU - Niemann, Carsten U.

AU - Awan, Farrukh T.

AU - Fogliatto, Laura

AU - Nikitin, Eugene

AU - Samoilova, Olga

AU - Habib, Adel

AU - Foroutanpour, Kayhan

AU - Kuptsova-Clarkson, Nataliya

AU - Opat, Stephen

N1 - Funding Information: Writing and editorial assistance were provided by Robert J. Schoen, PharmD, and Laura L. McCormick, PhD, of Peloton Advantage, an OPEN Health company, and funded by AstraZeneca.

PY - 2022/10/22

Y1 - 2022/10/22

UR - https://www.scopus.com/pages/publications/85148937657

U2 - 10.1097/HS9.0000000000000780

DO - 10.1097/HS9.0000000000000780

M3 - Article

C2 - 36168519

AN - SCOPUS:85148937657

SN - 2572-9241

VL - 6

SP - 1

EP - 4

JO - HemaSphere

JF - HemaSphere

IS - 10

M1 - E780

ER -

COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Access to Document

Other files and links

Cite this